SITEMAP 창 닫기

CEO & President Wonbum Lee
Sales Revenue(2018) 140.6 Mil USD
Stock Exchange Index KOSPI
Head Office Seoul, Korea
KGMP Plant Anseong, Korea
R&D center Suwon, Korea / Seoul, Korea
Main Therapeutic Areas Central Nervous System (79%)
Cardiovascular (6%)
Gastrointestinal (6%)
Main Products Risperidone/Quetiapine/Alprazolam